Follow us: @csjmagazine
Sponsored by
News
UK HealthTech: urgent action needed to remove persistent barriers
For the third year in a row, the challenges facing the UK’s HealthTech industry have continued to grow, the latest sector-wide study has revealed. Following a year marked by regulatory uncertainties and persistent, increasing barriers, the industry, which employs over 150,000 people, finds itself at a critical juncture. The data, captured by the Association of British
HealthTech Industries (ABHI) and CPI, highlight that regulatory concerns continue to cause half of the sector to delay bringing innovations to the UK. Additionally, 30% of companies are not bidding on NHS tenders due to unworkable requirements that are singularly focused on unit price - often below the cost of production - rather than the total value achieved across clinical pathways. According to the HealthTech sector, these
challenges are being compounded by the rollout of the NHS’s carbon reduction requirements, which despite being well-intended and having the fundamental backing of the industry, still lack clear guidance and support measures. Costs in regulation, sustainability, freight services, and labour have all risen at pace, almost matching those increases seen in 2023, despite the subsequent fall in inflation. The MHRA’s recently proposed fee increases are set to exacerbate the situation further, UK Health Tech leaders warn. The HealthTech sector is increasingly viewing the US as the most attractive market. The US polled most favourably across the majority of factors. Conversely, the UK polls behind both the EU and US in being a supportive place to grow a business, being able to adopt innovation at pace and scale, and having a translational research environment. The most concerning differential exists in creating a regulatory environment that encourages business investment and innovation. There are, however, causes for optimism. The sector views the UK as
the most attractive globally for its research friendly environment and ability to evaluate technologies for their clinical and cost effectiveness. These have historically been two areas of strength in the UK, with globally renowned institutions such as the National Institute for Health Research (NIHR) and the national Institute for Health and Care Excellence (NICE). There is also optimism regarding the
Government’s commitment to the HealthTech sector as a driver of economic growth. Over 30% of companies surveyed intend to expand their R&D and manufacturing investments in the UK, indicating confidence in future opportunities. Industry stakeholders are particularly enthusiastic about programmes such as the MHRA’s proposed international recognition framework, which is anticipated to significantly enhance the UK’s attractiveness, with four times as many companies favouring it over any other initiative. The survey data suggests that realising the
full potential of HealthTech is possible, but urgent action is required to address the challenges that reduce patient access to lifesaving and life- enhancing technologies, and which stifle innovation.
Peter Ellingworth, Chief Executive of ABHI, said, “UK HealthTech is at a crossroads. Regulatory uncertainties and NHS challenges are repeated hurdles that are driving companies, and consequently their technologies, to more receptive markets abroad. There is immense potential if we navigate these challenges wisely, and it is in the interest of the NHS and the patients that our industry serves to correct these trends. Immediate and prompt action is needed. The Government’s renewed focus is promising, and with strategic investments and clear policies, we can cement the UK’s position as a global hub for HealthTech.” Rahul Kapoor, Director of HealthTech, CPI
said: “The 2024 Business Survey highlights the challenging environment faced by the UK HealthTech sector, particularly due to regulatory uncertainty and rising costs. However, it also underscores the strength of our ecosystem, which includes a vibrant community of companies driving innovation and growth. To ensure the sector remains dynamic and exciting, we must provide further support and focus on key areas such as regulatory improvements, NHS procurement processes, and sustainability initiatives. “Furthermore, better communication across the industry facilitated through leadership groups to drill down into specific challenges that can be solved through public-private partnerships would be highly beneficial. This is especially linked to the critical need for more funding to accelerate innovation, which will help grow the UK HealthTech ecosystem as a global hub. This report offers valuable insights into how we can enhance the industry’s potential and continue to lead in HealthTech innovation.” Further details, and the full survey report, can be accessed at:
https://www.abhi.org.uk/resource- hub/file/19101
RCM calls for end to maternal mortality disparities
Women should not die simply because they are Black, Asian or poor. This is the stark message from the Royal College of Midwives (RCM) following the publication of the latest MBRRACE-UK report, Saving Lives, Improving Mothers’ Care, into maternal deaths during and immediately following pregnancy between 2020 and 2022. The report found a statistically significant
increase in maternal death rate in the UK between 2017-19 and 2020-22, and thrombosis and thromboembolism is now the leading cause of maternal death. Deaths from mental health-related causes continue to account for a large proportion
(34%) of deaths occurring between six weeks and a year after the end of pregnancy. In addition, women living in the most deprived areas continue to have the highest maternal mortality rates. There was a nearly three-fold difference in
maternal mortality rates among women from Black ethnic backgrounds and an almost two-fold difference among women from Asian ethnic backgrounds compared to White women. Gill Walton, Chief Executive of the RCM, said:
“Although there has been a slight narrowing of the gap, the fact is that there shouldn’t be one. Women should not die simply because they are Black, Asian
or poor. There is so much more all of us can do, from the provision of education and training, so that healthcare professionals, including midwives, obstetricians and paramedics, can identify and address conditions quickly and effectively, to better access to interpreter services in hospitals. “The new Government said that they wanted to
make this a priority. So do we, and we are ready to work with them to make a positive change.” The MBRRACE-UK report also makes six
recommendations aimed at improving maternal care. To view the full findings, visit: https://tinyurl. com/3n32xcf6
November 2024 I
www.clinicalservicesjournal.com 9
romaset -
stock.adobe.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80
